This CE activity is provided by the Meniscus Educational Institute. 
A Video Lecture based on the live local/regional lecture series: EGFR Inhibitors: Beyond the First Decade
Supported by an educational grant from ImClone Systems, Inc. 
Posting of the video on ManageCRC.com made available by an educational grant from sanofi-aventis U.S.
Release Date: June 2009
Termination Date: June 30, 2010
Faculty
Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP
Oncology Nursing Consultant and Assistant Clinical Professor
Department of Physiological Nursing
University of California, San Francisco
San Francisco, CA
Intended Audience
This continuing education activity is designed for oncology nurses and pharmacists at the generalist and advanced practice level who care for patients receiving EGFR inhibitor therapy and other health care professionals interested in this topic.
Overall Purpose
This program is designed to provide up-to-date information and easily applied clinical tools that will ensure familiarity with emerging EGFR inhibitor therapeutic options and integration into clinical practice. This knowledge will enable oncology clinicians to optimize outcomes for patients undergoing therapy with EGFR inhibitors.
Learning Objectives
After participating in this knowledge-based activity, participants should be able to
- Differentiate among EGFR inhibitor agents with regard to targets, indications, and side effect profiles
- Explain the current evidence related to EGFR testing and molecular markers
- Describe the current guidelines for the management of rash associated with EGFR inhibitors alone and in combination with radiation therapy
- Develop a plan of care for the patient experiencing toxicities associated with the use of EGFR inhibitors
- Formulate an education plan for patients receiving EGFR inhibitors
Continuing Education
Statement of Credit—Participants who successfully complete this activity (including completion and submission of the evaluation form and learning assessment) will be issued a statement of credit via e-mail within 4 weeks.
Nurses. This activity for 1.35 contact hours is provided by the Meniscus Educational Institute.
The Meniscus Educational Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation refers to recognition of educational activities only and does not imply approval or endorsement by the Meniscus Educational Institute or the American Nurses Credentialing Center’s Commission on Accreditation of any product mentioned.
Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 1.35 contact hours.
Pharmacists. This educational activity is sponsored by the Meniscus Educational Institute. The Meniscus Educational Institute is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The ACPE Universal Activity Number assigned to this program, for 1.35 contact hours (0.135 CEUs), is 429-999-09-004-H01-P.
ANCC Accreditation Feedback Line
1-866-262-9730
The Accreditation Program of the American Nurses Credentialing Center is interested in the opinions and perspectives of the participants in accredited continuing nursing education activities, particularly perspectives related to the presence of perceived bias* in an activity. For this reason, we provide a toll-free telephone number, which participants may call at any time to tell us about
- Any noted bias or conflict of interest in the education
- Any concerns, compliments, or opinions
- A great experience
- An unpleasant experience
- Your thoughts on the process
Just call and tell us!
1-866-262-9730
*Bias is defined as preferential influence that causes a distortion of opinion or facts. Commercial bias may occur when an educational activity promotes one or more product(s) (drugs, devices, services, software, hardware, etc). This definition is not all inclusive, and participants may use their own interpretation in deciding whether a presentation is biased.
NOTE: statements of commercial support and/or conflict of interest disclosures do not represent bias. Such statements inform the learner that the provider has implemented a mechanism to identify and resolve all conflicts of interest prior to delivery of the educational material.
Product Disclosures
Reflecting standard oncology practice, which often requires uses and dosages for therapeutic products that have not been approved by the US Food and Drug Administration, this educational activity includes information about many drugs. All faculty participating in continuing education activities are expected to disclose the approved or investigational status (related to the subject matter of this activity EGFR inhibitors) of all products and devices under discussion. This information, as of the time of posting, is summarized briefly in the table here. In addition, primary references and full prescribing information should be consulted for complete information. Clinicians have the professional responsibility to ensure that drugs are prescribed and used appropriately, based on their own clinical judgment and accepted standards of care.
There is no fee for participating in this activity.
Disclaimer
This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Meniscus Educational Institute educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.
The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by MEI or the companies providing educational grant support of any specific therapeutics or approaches to diagnosis or patient management.
Download Activity
By selecting the link below you acknowledge that you have read the CE information and would like to proceed with the activity.
Resources to download:
Instructions for Completion
To successfully complete this activity and receive continuing education credit, you must review the entire video lecture, score at least 70% on the learning assessment, and complete the evaluation form. You can access the learning assessment and evaluation form by selecting the link below. If you provide your e-mail address, you will receive an immediate e-mail notification with a link to your printable statement of credit.
Click here to register and submit your learning assessment and evaluation form online.